Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar in Relapsed Peripheral T-cell Non-Hodgkin Lymphoma
2008-000306-36Phase 2Terminated
- Sponsor
- Region Skåne
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib in peripheral T-cell lymphoma (PTCL) and T-cell lymphoma, sponsored by Region Skåne. Primary endpoint: Progression-free survival. Started Oct 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
peripheral T-cell lymphoma (PTCL)T-cell lymphoma
Beyond the preview
Go deeper on 2008-000306-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000306-36.